[VYNE] YoY Annual Result on 31-Dec-2019 [#FY]

Stock
[VYNE] VYNE Therapeutics Inc.
Announcement Date
03-Mar-2020
Financial Year
2019
Quarter
31-Dec-2019 [#FY]
Profit Trend
YoY- -36.97%
Quarter Report
VYNE's Result
VYNE's Financial Summary
View:
Show?
Annual Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 477 14,755 20,993 443 10,640 4,582 674 -5.59%
PBT -33,932 -73,777 -255,826 -73,703 -51,445 -29,076 -14,068 15.79%
Tax 13 -448 -258 -3,239 3,090 -8 0 -
NP -33,945 -73,329 -255,568 -70,464 -51,445 -29,076 -14,068 15.80%
Tax Rate - - - - - - - -
Total Cost 34,422 88,084 276,561 70,907 62,085 33,658 14,742 15.17%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -7,116.35 -496.98 -1,217.40 -15,906.09 -483.51 -634.57 -2,087.24 22.67%
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -10.65 -25.65 -141.90 -149.48 -170.94 -101.65 -87.78 -29.62%
EPS Diluted -10.65 -25.65 -141.90 -149.48 -170.94 -101.65 -87.78 -29.62%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.